These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21557643)

  • 21. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosslinking of decellularized porcine heart valve matrix by procyanidins.
    Zhai W; Chang J; Lin K; Wang J; Zhao Q; Sun X
    Biomaterials; 2006 Jul; 27(19):3684-90. PubMed ID: 16513164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gal-knockout bioprostheses exhibit less immune stimulation compared to standard biological heart valves.
    McGregor CG; Kogelberg H; Vlasin M; Byrne GW
    J Heart Valve Dis; 2013 May; 22(3):383-90. PubMed ID: 24151765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo efficacy for novel combined anticalcification treatment of glutaraldehyde-fixed cardiac xenograft using humanized mice.
    Lim HG; Choi SY; Jeong S; Shin JS; Park CG; Kim YJ
    J Biomater Appl; 2015 Feb; 29(7):929-40. PubMed ID: 25245780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
    Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P
    J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and αGal epitopes and is reduced in healthy vegetarian subjects.
    Böer U; Buettner FFR; Schridde A; Klingenberg M; Sarikouch S; Haverich A; Wilhelmi M
    Xenotransplantation; 2017 Mar; 24(2):. PubMed ID: 28101961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions.
    Gong G; Seifter E; Lyman WD; Factor SM; Blau S; Frater RW
    J Heart Valve Dis; 1993 Nov; 2(6):684-93. PubMed ID: 7719511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.
    McGregor CG; Carpentier A; Lila N; Logan JS; Byrne GW
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):269-75. PubMed ID: 21168032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation.
    O'Brien MF; Goldstein S; Walsh S; Black KS; Elkins R; Clarke D
    Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):194-200. PubMed ID: 10660192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of novel combined anticalcification protocols including immunologic modification for prolonged durability of cardiac xenograft: preclinical study using large-animal long-term circulatory models.
    Lim HG; Jeong S; Shin JS; Park CG; Kim YJ
    ASAIO J; 2015; 61(1):87-95. PubMed ID: 25303800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recellularization of decellularized mitral heart valves in juvenile pigs.
    Hønge JL; Funder JA; Jensen H; Dohmen PM; Konertz WF; Hasenkam JM
    J Heart Valve Dis; 2010 Sep; 19(5):584-92. PubMed ID: 21053736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural changes of glutaraldehyde- treated porcine bioprosthetic valves.
    Camilleri JP; Pornin B; Carpentier A
    Arch Pathol Lab Med; 1982 Oct; 106(10):490-6. PubMed ID: 6812544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts.
    Barone A; Benktander J; Teneberg S; Breimer ME
    Xenotransplantation; 2014; 21(6):510-22. PubMed ID: 25041314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo.
    Xi T; Ma J; Tian W; Lei X; Long S; Xi B
    J Biomed Mater Res; 1992 Sep; 26(9):1241-51. PubMed ID: 1429769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes.
    Cicha I; Rüffer A; Cesnjevar R; Glöckler M; Agaimy A; Daniel WG; Garlichs CD; Dittrich S
    Cardiovasc Pathol; 2011; 20(4):222-31. PubMed ID: 20598910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
    Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
    Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
    Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
    Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of elastin in pathologic calcification of xenograft heart valves.
    Bailey MT; Pillarisetti S; Xiao H; Vyavahare NR
    J Biomed Mater Res A; 2003 Jul; 66(1):93-102. PubMed ID: 12833435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation.
    Stone KR; Abdel-Motal UM; Walgenbach AW; Turek TJ; Galili U
    Transplantation; 2007 Jan; 83(2):211-9. PubMed ID: 17264818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection.
    Manji RA; Zhu LF; Nijjar NK; Rayner DC; Korbutt GS; Churchill TA; Rajotte RV; Koshal A; Ross DB
    Circulation; 2006 Jul; 114(4):318-27. PubMed ID: 16831988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.